Tongling Jieya Biotechnology Co., Ltd. Achieved an Operating Revenue of Approximately RMB 772 Million

 In 2025, Tongling Jieya Biotechnology Co., Ltd. recorded operating revenue of approximately RMB 772 million, up 41.02% year-on-year. Its net profit attributable to shareholders of the listed company was about RMB 77.27 million, jumping 296.97% year-on-year, and basic earnings per share stood at RMB 0.68, an increase of 300.00% year-on-year.